News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,665 Results
Type
Article (2359)
Company Profile (39)
Press Release (34267)
Section
Business (14054)
Career Advice (76)
Deals (2066)
Drug Delivery (7)
Drug Development (4055)
Employer Resources (10)
FDA (422)
Job Trends (755)
News (20008)
Policy (1050)
Tag
Academia (143)
Africa (42)
Alliances (3428)
Alzheimer's disease (39)
Antibody-drug conjugate (ADC) (5)
Approvals (420)
Arizona (12)
Artificial intelligence (4)
Asia (1792)
Australia (291)
Bankruptcy (10)
Best Places to Work (464)
Biosimilars (9)
Biotechnology (31)
C2C Services and Suppliers (1970)
California (231)
Canada (45)
Cancer (22)
Career advice (64)
Cell therapy (8)
China (7)
Clinical research (2988)
Collaboration (15)
Compensation (6)
Connecticut (7)
COVID-19 (174)
Data (5)
Diagnostics (451)
Drug pricing (4)
Earnings (4047)
Employer resources (8)
Europe (3709)
Events (5710)
Executive appointments (4)
FDA (425)
Florida (11)
Funding (12)
Gene editing (6)
Gene therapy (5)
GLP-1 (43)
Government (145)
Healthcare (692)
Hotbed/Location (27290)
Illinois (10)
Indiana (12)
Infectious disease (174)
Inflammatory bowel disease (9)
Inflation Reduction Act (5)
Interviews (7)
IPO (957)
IRA (5)
Job creations (289)
Job search strategy (62)
Kansas (12)
Layoffs (31)
Legal (207)
Liver cancer (5)
Lung cancer (7)
Management (4)
Manufacturing (4)
Maryland (10)
Massachusetts (69)
Medical device (296)
Medtech (296)
Mergers & acquisitions (1111)
Metabolic disorders (6)
Minnesota (7)
Neuroscience (46)
New Jersey (8)
New York (12)
NextGen Class of 2024 (347)
Non-profit (152)
North Carolina (52)
Northern California (103)
Ohio (16)
Opinion (13)
Patents (6)
Pennsylvania (10)
People (5429)
Phase I (1283)
Phase II (1507)
Phase III (810)
Pipeline (5)
Podcasts (4)
Policy (7)
Postmarket research (30)
Preclinical (562)
Real estate (417)
Recruiting (5)
Regulatory (752)
Reports (5)
Research institute (141)
Resumes & cover letters (9)
South America (40)
Southern California (115)
Startups (485)
Texas (7)
United States (506)
Vaccines (18)
Washington State (6)
Date
Last 7 days (37)
Last 30 days (150)
Last 365 days (2810)
2024 (1817)
2023 (2858)
2022 (3752)
2021 (4049)
2020 (3471)
2019 (2061)
2018 (1565)
2017 (1799)
2016 (1624)
2015 (1834)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
36,665 Results for "anixa biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. today announced that it has treated the sixth patient in the ongoing Phase 1 clinical trial.
June 24, 2024
·
5 min read
Drug Development
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fifth patient in its ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
May 21, 2024
·
4 min read
Biotech Bay
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
Anixa Biosciences, Inc., a clinical-stage biotechnology company focused on the treatment and prevention of cancer, announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.
May 8, 2024
·
5 min read
Biotech Bay
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Anixa Biosciences, Inc. today announced its participation in the Sidoti Micro-Cap Virtual Conference, taking place May 8-9, 2024.
April 30, 2024
·
3 min read
Business
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences, Inc today announced the appointment of Sanjay Juneja, MD to its Cancer Business Advisory Board.
April 18, 2024
·
4 min read
Biotech Bay
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Anixa Biosciences, Inc. today announced that Dr. Amit Kumar , Chairman and CEO of Anixa, will participate in the 24th Annual World Vaccine Congress being held April 1-4, 2024.
March 11, 2024
·
3 min read
Press Releases
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024
·
3 min read
Press Releases
Anixa Biosciences Announces $5 Million Share Repurchase Program
July 15, 2024
·
3 min read
Press Releases
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
July 17, 2024
·
4 min read
Biotech Bay
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Anixa Biosciences, Inc. today announced that it will host its 2024 Annual Meeting of Stockholders (the “Meeting”) on Thursday, March 21, 2024 at 10:00 a.m. Pacific Time in a virtual format.
March 14, 2024
·
3 min read
1 of 3,667
Next